Arkolith/Insider Trading/TXMD/Form 4

Walker Marlan D

Chief Executive OfficerTherapeuticsMD, Inc. (TXMD) · full profile →Form 4 · filed Apr 15, 2025
Net Buying
Open-Market Buys
$490
Open-Market Sells
$0
Net Open-Market Flow
$490
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 14, 2025Buy(P)490$1.00$49074K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-25-001215) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML